Marina Frimer

5PUBLICATIONS
56CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

|May 18, 2026
Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally Diverse Cohort.

|Apr 22, 2026
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

|Feb 19, 2026
Ancestrally Diverse Autologous Patient-Derived Organoid-Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcome Disparities in High-Grade Endometrial Cancer.

Charlie Chung, Brian Yueh, Santhilal Subhash

|Oct 30, 2021
Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?

Risha Sinha, Aaron Nizam, Weiwei Shan

Pageof 1

Frequent Collaborators

2 joint publications

Susan Halabi

2 joint publications

Aaron Nizam

2 joint publications

Dominique C Hinshaw

2 joint publications

Ramya Thota